Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Förster-Ruhrmann

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
HNO|February 27, 2024
[Does aspirin therapy after desensitization still have a role in treatment of chronic rhinosinusitis with nasal polyposis in the era of biologics?]F Klimek, U Förster-Ruhrmann, J Hagemann, et al.
Revista Portuguesa De Pneumologia|October 21, 2015
Long-term clinical effects of aspirin-desensitization therapy among patients with poorly controlled asthma and non-steroidal anti-inflammatory drug hypersensitivity: An exploratory studyU Förster-Ruhrmann, S-M Zappe, A J Szczepek, et al.
HNO|May 10, 2019
[Nasal provocation with increased ASA dose: improved "non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated disease" (N‑ERD) detection rate in chronic rhinosinusitis patients]U Förster-Ruhrmann, W Behrbohm, G Pierchalla, et al.
Laryngo- Rhino- Otologie|April 2, 2020
, L Klimek, U Förster-Ruhrmann, et al.
HNO|February 3, 2026
[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 3: Hypersensitivity reactions of type VI]L Klimek, S Becker, B Haxel, et al.
HNO|December 29, 2025
[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 2: Hypersensitivity reactions of type V (epithelial barrier defects)]L Klimek, S Becker, B Haxel, et al.
HNO|April 8, 2025
[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 1: Hypersensitivity reactions of type IVa-c as a correlate to T1, T2, and T3 endotypes]L Klimek, S Becker, B Haxel, et al.
Rhinology|July 7, 2025
Multi-centric real-world effectiveness of mepolizumab in severe chronic rhinosinusitis with nasal polyps in GermanyF Bärhold, J Hagemann, L Klimek, et al.
Laryngo- Rhino- Otologie|September 30, 2021
L Klimek, U Förster-Ruhrmann, A G Beule, et al.
Laryngo- Rhino- Otologie|June 24, 2020
L Klimek, U Förster-Ruhrmann, S Becker, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
HNO|February 27, 2024
[Does aspirin therapy after desensitization still have a role in treatment of chronic rhinosinusitis with nasal polyposis in the era of biologics?]F Klimek, U Förster-Ruhrmann, J Hagemann, et al.
Revista Portuguesa De Pneumologia|October 21, 2015
Long-term clinical effects of aspirin-desensitization therapy among patients with poorly controlled asthma and non-steroidal anti-inflammatory drug hypersensitivity: An exploratory studyU Förster-Ruhrmann, S-M Zappe, A J Szczepek, et al.
HNO|May 10, 2019
[Nasal provocation with increased ASA dose: improved "non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated disease" (N‑ERD) detection rate in chronic rhinosinusitis patients]U Förster-Ruhrmann, W Behrbohm, G Pierchalla, et al.
Laryngo- Rhino- Otologie|April 2, 2020
, L Klimek, U Förster-Ruhrmann, et al.
HNO|February 3, 2026
[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 3: Hypersensitivity reactions of type VI]L Klimek, S Becker, B Haxel, et al.
HNO|December 29, 2025
[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 2: Hypersensitivity reactions of type V (epithelial barrier defects)]L Klimek, S Becker, B Haxel, et al.
HNO|April 8, 2025
[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 1: Hypersensitivity reactions of type IVa-c as a correlate to T1, T2, and T3 endotypes]L Klimek, S Becker, B Haxel, et al.
Rhinology|July 7, 2025
Multi-centric real-world effectiveness of mepolizumab in severe chronic rhinosinusitis with nasal polyps in GermanyF Bärhold, J Hagemann, L Klimek, et al.
Laryngo- Rhino- Otologie|September 30, 2021
L Klimek, U Förster-Ruhrmann, A G Beule, et al.
Laryngo- Rhino- Otologie|June 24, 2020
L Klimek, U Förster-Ruhrmann, S Becker, et al.
Pageof 2